Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients (Q41138015)

27 September 2017

Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients (English)

1 reference

27 September 2017

1 reference

1 reference

F Dronda

1

1 reference

27 September 2017

M Alonso-Sanz

2

1 reference

27 September 2017

F Laguna

3

1 reference

27 September 2017

F Chaves

4

1 reference

27 September 2017

J V Martínez-Suárez

5

1 reference

27 September 2017

J L Rodríguez-Tudela

6

1 reference

27 September 2017

A González-López

7

1 reference

27 September 2017

E Valencia

8

1 reference

27 September 2017

1 June 1996

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

27 September 2017

1 reference

27 September 2017

15

1 reference

27 September 2017

6

1 reference

27 September 2017

446-452

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01691310

27 September 2017

0 references

cites work

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Improved medium for fluconazole susceptibility testing of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Epidemiology and control of fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691310

Oral azole drugs as systemic antifungal therapy

21 January 2018

1 reference

12 December 2020

Multicenter evaluation of four methods of yeast inoculum preparation

1 reference

12 December 2020

Fluconazole and Candida krusei fungemia.

1 reference

12 December 2020

Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.

1 reference

12 December 2020

Esophagitis caused by fluconazole-resistant Candida albicans: therapeutic failure and in vitro correlation

1 reference

12 December 2020

Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

Fluconazole resistance in AIDS patients

1 reference

12 December 2020

Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group

1 reference

12 December 2020

Fluconazole-resistant Candida albicans after long-term suppressive therapy

1 reference

12 December 2020

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

1 reference

12 December 2020

Fluconazole resistant candida in AIDS.

1 reference

12 December 2020

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

12 December 2020

Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients

1 reference

12 December 2020

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

12 December 2020

Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of fluconazole in humans

1 reference

12 December 2020

Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.

1 reference

12 December 2020

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

12 December 2020

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

12 December 2020

Candida albicans resistance in AIDS

1 reference

12 December 2020

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691310

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference